ArticleJBRA assisted reproduction2025
Remote fertility care: Are patients prepared to forego physician proximity in favor of accessibility?
Article in JBRA assisted reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of infertility is rising rapidly, affecting approximately one in every six individuals worldwide and impacting nearly 200 million people. Access to assisted reproductive technologies (ART) remains limited, as most countries fail to provide adequate ART services to those in need. Economic barriers are among the most significant obstacles to ART access. However, treatment costs rarely account for additional expenses such as transportation, accommodation, or lost work hours required for clinic visits, including consultations, monitoring exams, and procedures. These overlooked costs further increase the financial burden on patients. To mitigate geographical barriers, telehealth and remote monitoring technologies have emerged as promising solutions. Studies indicate that telehealth, when combined with remote ultrasound monitoring performed by local gynecologists, yields clinical outcomes comparable to traditional in-clinic monitoring, with high patient satisfaction. The development of remote ultrasound devices aims to enhance ART accessibility for patients facing logistical constraints. Research has demonstrated that these devices are non-inferior to conventional monitoring, providing similar oocyte and embryo outcomes while offering additional benefits such as increased patient autonomy, discretion, reduced stress, and lower costs. A survey of 146 Brazilian infertility patients assessed their acceptance of the remote ultrasound device, revealing that 88.3% were willing to conduct ultrasounds at home, provided that the image quality and diagnostic accuracy were comparable to those of clinic-based examinations. While infertility patients appear receptive to remote fertility care, concerns persist regarding the efficiency and reliability of remote monitoring. Therefore, identifying the most suitable patient profile for this approach is essential, with those already familiar with ART processes potentially being the most appropriate candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.